An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Concerns
However, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.
Several experts said the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.
Service Response and Content Elimination
Based on the social media company, the service has taken down violative content and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to nine thousand members marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.
After minutes of joining one group, a seller posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Within these groups, posts display dark colored packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to potentially significant health risks”.
